Sandu Pharmaceuticals Ltd — Important, 18-05-2026: Company Update

Sandu Pharmaceuticals has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms the company's general adherence to applicable regulatory provisions. A minor past observation regarding a delay in submitting financial results for the prior year (FY25), which resulted in a fine of INR 30,000, has been rectified with the payment made. This indicates the company is addressing its compliance obligations. Overall, the report highlights a compliant operational status for the review period, reassuring stakeholders about its regulatory practices.